Trial Profile
Phase 1 study of single, escalating subcutaneous doses of LY 2189265 in volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Eli Lilly and Company
- 05 Nov 2010 New trial record.